Published in Biochem Biophys Res Commun on September 26, 2010
Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ Res (2012) 1.15
Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am J Physiol Heart Circ Physiol (2013) 0.85
Emerging concepts in liver graft preservation. World J Gastroenterol (2015) 0.84
Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci (Lond) (2012) 0.81
Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats. J Trauma Acute Care Surg (2013) 0.80
Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism. J Burn Care Res (2014) 0.77
Proteasome Inhibition After Burn Injury. J Burn Care Res (2016) 0.77
Relevance of Endoplasmic Reticulum Stress Cell Signaling in Liver Cold Ischemia Reperfusion Injury. Int J Mol Sci (2016) 0.75
Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death. PLoS One (2016) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A (1999) 5.28
Proteasome inhibitors: from research tools to drug candidates. Chem Biol (2001) 5.06
Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat (2008) 2.13
Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem (2001) 1.97
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol (2002) 1.79
Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res (2010) 1.78
Physiological levels of ATP negatively regulate proteasome function. Cell Res (2010) 1.44
Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal (2005) 1.40
Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Biochim Biophys Acta (2004) 1.36
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J Mol Cell Cardiol (2006) 1.28
Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys (2006) 1.20
Patented small molecule inhibitors in the ubiquitin proteasome system. BMC Biochem (2007) 1.19
Advances in and applications of proteasome inhibitors. Curr Opin Chem Biol (2008) 1.17
Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits. Circ Res (2010) 1.17
Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med (2008) 1.12
Proteasome inhibition during myocardial infarction. Cardiovasc Res (2009) 1.10
Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke (2000) 1.10
Retracted Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol (2005) 1.08
Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol (1999) 1.08
Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol (1989) 1.03
Organ preservation. Methods Mol Biol (2006) 1.00
A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun (2009) 0.99
Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochem Biophys Res Commun (2007) 0.98
Immunological methods to quantify and characterize proteasome complexes: development and application. J Immunol Methods (2008) 0.96
Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant (2010) 0.96
Functional alterations of cardiac proteasomes under physiological and pathological conditions. Cardiovasc Res (2009) 0.94
Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med (2006) 0.91
A proteasome inhibitor effectively prevents mouse heart allograft rejection. Transplantation (2001) 0.86
Cardiac transplantation: the alternate list and expansion of the donor pool. Curr Opin Cardiol (2004) 0.84
Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatol Res (2007) 0.80
Oxygen-derived free radicals and postischemic myocardial reperfusion: therapeutic implications. Fundam Clin Pharmacol (1990) 0.80
Adenine nucleotide catabolism in human myocardium during heart and heart-lung transplantation. Eur J Cardiothorac Surg (1992) 0.78
Proteasome inhibition attenuates renal endothelin-1 production and the development of ischemic acute renal failure in rats. J Cardiovasc Pharmacol (2000) 0.77
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Metastatic renal cell carcinoma. Curr Treat Options Oncol (2003) 2.50
Comparison of routine chest radiograph versus clinician judgment to determine adequate central line placement in critically ill patients. J Trauma (2007) 2.10
Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med (2006) 1.88
Morbidity and survival probability in burn patients in modern burn care. Crit Care Med (2015) 1.67
Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases. Virchows Arch (2012) 1.67
Exacerbation of intestinal permeability in rats after a two-hit injury: burn and Enterococcus faecalis infection. Crit Care Med (2004) 1.66
The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury. Crit Care Med (2012) 1.62
Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol (2008) 1.62
Half-a-dozen ribs: the breakpoint for mortality. Surgery (2005) 1.62
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Expanding the morphologic spectrum of adult biphasic renal tumors--mixed epithelial and stromal tumor of the kidney with focal papillary renal cell carcinoma: case report and review of the literature. Int J Surg Pathol (2013) 1.52
Systemic release of cytokines and heat shock proteins in porcine models of polytrauma and hemorrhage*. Crit Care Med (2012) 1.51
Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma. Crit Care Med (2012) 1.50
Identity crisis--bladder cells in vascular biology. Toxicol In Vitro (2010) 1.47
Intraabdominal complications after lung transplantation. J Am Coll Surg (2006) 1.47
CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem (2010) 1.47
Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skin. Crit Care Med (2014) 1.47
Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol (2007) 1.47
Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus. Am J Kidney Dis (2007) 1.45
Medicare's "Global" terrorism: where is the pay for performance? J Trauma (2008) 1.43
Analysis of compliance and outcomes in a trauma system with a 2-hour transfer rule. Arch Surg (2010) 1.42
Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats. Clin Exp Pharmacol Physiol (2009) 1.42
The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg (2007) 1.41
Broken bones and orthopedist groans: can an acute care surgeon fix both? J Trauma (2008) 1.38
The evolving characteristics and care of necrotizing soft-tissue infections. Burns (2005) 1.37
Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A (2010) 1.33
Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in alcohol intoxication and burn injury. Alcohol (2004) 1.27
Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am J Physiol Gastrointest Liver Physiol (2002) 1.26
Inflammation and the host response to injury: an overview of the multicenter study of the genomic and proteomic response to burn injury. J Burn Care Res (2006) 1.25
Standard operating procedures for the clinical management of patients enrolled in a prospective study of Inflammation and the Host Response to Thermal Injury. J Burn Care Res (2007) 1.24
The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. J Biol Chem (2011) 1.23
Role of the gastrointestinal tract in burn sepsis. J Burn Care Rehabil (2005) 1.23
The burden of "sticky" amyloid: typing challenges. Arch Pathol Lab Med (2007) 1.21
Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med (2006) 1.16
Metastatic juxtaglomerular cell tumor in a 52-year-old man. Am J Surg Pathol (2004) 1.14
Inhalation injury, pulmonary perturbations, and fluid resuscitation. J Burn Care Res (2007) 1.14
Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injury. J Burn Care Res (2008) 1.13
Immunologic responses to critical injury and sepsis. J Intensive Care Med (2006) 1.12
Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen (2003) 1.12
Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med (2008) 1.12
Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.11
Effects of ethanol on pulmonary inflammation in postburn intratracheal infection. J Burn Care Res (2008) 1.09
Early acute kidney injury predicts progressive renal dysfunction and higher mortality in severely burned adults. J Burn Care Res (2010) 1.08
Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function. Burns (2005) 1.06
Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem (2013) 1.05
Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med (2007) 1.04
Mechanism of injury does not predict acuity or level of service need: field triage criteria revisited. Surgery (2003) 1.03
Toxic epidermal necrolysis: does immunoglobulin make a difference? J Burn Care Rehabil (2004) 1.02
Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum Pathol (2008) 1.02
Ubiquitin reduces contusion volume after controlled cortical impact injury in rats. J Neurotrauma (2007) 1.01
Ubiquitin reduces fluid shifts after traumatic brain injury. Surgery (2005) 1.01
Treatment strategies in toxic epidermal necrolysis syndrome: where are we at? J Burn Care Res (2008) 1.00
Inflammatory response in multiple organs in a mouse model of acute alcohol intoxication and burn injury. J Burn Care Res (2011) 1.00
Old fashion clinical judgment in the era of protocols: is mandatory chest X-ray necessary in injured patients? J Trauma (2005) 1.00
Norepinephrine modulates the inflammatory and proliferative phases of wound healing. J Trauma (2006) 0.99
A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun (2009) 0.99
Inhalation injury severity and systemic immune perturbations in burned adults. Ann Surg (2013) 0.99
Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Arch Pathol Lab Med (2005) 0.99
Early pulmonary immune hyporesponsiveness is associated with mortality after burn and smoke inhalation injury. J Burn Care Res (2012) 0.98
Ten year experience of burn, trauma, and combined burn/trauma injuries comparing outcomes. J Trauma (2004) 0.97
A primer in cytokines. J Burn Care Rehabil (2005) 0.97
Bone marrow norepinephrine mediates development of functionally different macrophages after thermal injury and sepsis. Ann Surg (2004) 0.97
Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem (2011) 0.96
Aging and animal models of systemic insult: trauma, burn, and sepsis. Shock (2009) 0.96
Resuscitation with pressors after traumatic brain injury. J Am Coll Surg (2005) 0.96
Murine hematopoietic stem cells and progenitors express adrenergic receptors. J Neuroimmunol (2007) 0.95
A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukoc Biol (2003) 0.95
Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Arch Pathol Lab Med (2007) 0.95
Propranolol restores the tumor necrosis factor-alpha response of circulating inflammatory monocytes and granulocytes after burn injury and sepsis. J Burn Care Res (2009) 0.94
The effect of thrombocytopenia on dermal wound healing. J Invest Dermatol (2003) 0.94
Corticosterone suppresses mesenteric lymph node T cells by inhibiting p38/ERK pathway and promotes bacterial translocation after alcohol and burn injury. Am J Physiol Regul Integr Comp Physiol (2005) 0.94
Prolongation of skin graft survival by exogenous ubiquitin. Transplantation (2006) 0.93
Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch Pathol Lab Med (2005) 0.93
Building a better fluid for emergency resuscitation of traumatic brain injury. J Trauma (2004) 0.92
The early acute phase response after burn injury in mice. J Burn Care Res (2007) 0.92
Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation. J Am Coll Surg (2013) 0.91
Burn injury and pulmonary sepsis: development of a clinically relevant model. J Trauma (2004) 0.91
Mild obesity is protective after severe burn injury. Ann Surg (2013) 0.91
The effect of sepsis on wound healing. J Surg Res (2002) 0.90
Norepinephrine-mediated suppression of phagocytosis by wound neutrophils. J Surg Res (2008) 0.90
Perturbed bone marrow monocyte development following burn injury and sepsis promote hyporesponsive monocytes. J Burn Care Res (2008) 0.90
Socioeconomic factors, medicolegal issues, and trauma patient transfer trends: Is there a connection? J Trauma (2006) 0.89
Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha- and beta-adrenoreceptor dependent pathways. Surgery (2007) 0.89
Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages. J Trauma (2007) 0.89
Neurosurgical coverage: essential, desired, or irrelevant for good patient care and trauma center status. Ann Surg (2005) 0.89
A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options. Am J Respir Cell Mol Biol (2012) 0.89
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Kidney Int (2004) 0.89
Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol (2006) 0.89
Reasons to omit digital rectal exam in trauma patients: no fingers, no rectum, no useful additional information. J Trauma (2005) 0.89
Implications of alcohol intoxication at the time of burn and smoke inhalation injury: an epidemiologic and clinical analysis. J Burn Care Res (2013) 0.88